P Richette, M Doherty, E Pascual, V Barskova… - Annals of the …, 2017 - ard.bmj.com
Background New drugs and new evidence concerning the use of established treatments have become available since the publication of the first European League Against …
P Richette, M Doherty, E Pascual, V Barskova… - Annals of the …, 2020 - ard.bmj.com
Although gout is the most common inflammatory arthritis, it is still frequently misdiagnosed. New data on imaging and clinical diagnosis have become available since the first EULAR …
Gout is a crystal-deposition disease that results from chronic elevation of uric acid levels above the saturation point for monosodium urate (MSU) crystal formation. Initial presentation …
M Hui, A Carr, S Cameron, G Davenport… - …, 2017 - academic.oup.com
Gout is the most common cause of inflammatory arthritis worldwide. In UK general practice, the overall prevalence has increased from 1.4% in 1999 to 2.49% in 2012 [1], despite the …
D Khanna, JD Fitzgerald, PP Khanna… - Arthritis care & …, 2012 - Wiley Online Library
Gout is a disorder that manifests as a spectrum of clinical and pathologic features built on a foundation of an excess body burden of uric acid, manifested in part by hyperuricemia …
E Roddy, HK Choi - Rheumatic Disease Clinics, 2014 - rheumatic.theclinics.com
Gout is a crystal deposition disease that arises when supersaturation of body tissues with urate occurs, leading to the formation of monosodium urate (MSU) crystals in and around …
E Roddy, M Doherty - Arthritis research & therapy, 2010 - Springer
Gout is the most prevalent form of inflammatory arthropathy. Several studies suggest that its prevalence and incidence have risen in recent decades. Numerous risk factors for the …
N Dalbeth, A Phipps-Green, C Frampton… - Annals of the …, 2018 - ard.bmj.com
Objectives To provide estimates of the cumulative incidence of gout according to baseline serum urate. Methods Using individual participant data from four publicly available cohorts …